"It's not always Type 2." – Overcoming Adult-Onset T1D Misdiagnosis

"We're throwing out all of our Type 2 treatments and they're not working... because what actually is underlying is Type 1." — Dr. Melissa Putman 👉 Watch the full clinical panel on-demand: lucemhealth.com/t1d-webinar Because Type 2 diabetes is so common in adult patient populations, elevated A1C levels are often met with a knee-jerk diagnosis of Type 2. Unfortunately, this clinical blind spot regularly misses slow-onset Type 1 Diabetes in adults, leading to ineffective treatments and prolonged patient distress. In this featured excerpt, Dr. Melissa S. Putman (Adult and Pediatric Endocrinologist at Massachusetts General Hospital) discusses the distinct clinical presentations of adult-onset T1D, why standard Type 2 treatments fail these patients, and how primary care providers can keep an open mind to avoid costly misdiagnoses. To help healthcare systems, pediatricians, and clinical leaders operationalize screening at scale, the full roundtable panel breaks down: Expanding the Screening Framework: Discover why relying strictly on family history misses the vast majority of new cases, and how proactive screening prevents critical late-stage complications. Navigating the Primary Care Bottleneck: Analyze the systemic barriers that make busy primary care clinics hesitate to screen, and explore the distinct clinical presentation differences between pediatric and adult-onset disease. Overcoming Operational Barriers: Transition from traditional venous blood draws to simple capillary finger-stick testing, and leverage virtual “hub-and-spoke” monitoring clinics to support primary care. New Options for Patients Living with T1D: Unpack the metabolic value of preserving endogenous insulin, and learn why delaying clinical onset until the young-adult transition window (ages 18–23) dramatically improves long-term self-management. Securing Coverage & Ensuring Equitable Care: Review real-world insurance coverage, denial management, and the ethical necessity of reaching community clinics and underserved populations. 🎬 Access the complete panel discussion here: 👉 lucemhealth.com/t1d-webinar